Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,644 | 104 | 99.3% |
| Education | $11.71 | 1 | 0.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $292.02 | 19 | $0 (2024) |
| PFIZER INC. | $162.66 | 11 | $0 (2023) |
| AstraZeneca Pharmaceuticals LP | $120.58 | 6 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $104.74 | 6 | $0 (2019) |
| Amgen Inc. | $100.59 | 5 | $0 (2019) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $93.41 | 6 | $0 (2018) |
| Takeda Pharmaceuticals U.S.A., Inc. | $82.11 | 6 | $0 (2018) |
| Shire North American Group Inc | $77.04 | 5 | $0 (2019) |
| Lilly USA, LLC | $70.45 | 5 | $0 (2022) |
| Allergan, Inc. | $64.94 | 4 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $29.45 | 2 | AstraZeneca Pharmaceuticals LP ($15.50) |
| 2023 | $121.66 | 7 | ABBVIE INC. ($34.67) |
| 2022 | $197.07 | 12 | Novo Nordisk Inc ($60.28) |
| 2021 | $61.48 | 4 | Novo Nordisk Inc ($28.97) |
| 2020 | $47.14 | 3 | PFIZER INC. ($19.12) |
| 2019 | $471.04 | 29 | Novo Nordisk Inc ($95.92) |
| 2018 | $661.30 | 45 | Boehringer Ingelheim Pharmaceuticals, Inc. ($93.41) |
| 2017 | $66.75 | 3 | Janssen Pharmaceuticals, Inc ($35.82) |
All Payment Transactions
105 individual payment records from CMS Open Payments — Page 3 of 5
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 03/22/2019 | SANOFI PASTEUR INC. | FLUZONE HIGH-DOSE (Drug), FLUZONE QUADRIVALENT, FLUBLOK QUADRIVALENT | Food and Beverage | In-kind items and services | $12.82 | General |
| Category: VACCINES | ||||||
| 03/18/2019 | Shire North American Group Inc | VYVANSE (Drug) | Food and Beverage | In-kind items and services | $19.42 | General |
| Category: NEUROSCIENCE | ||||||
| 02/19/2019 | Merck Sharp & Dohme Corporation | JANUVIA (Drug), BELSOMRA, JANUMET XR | Food and Beverage | In-kind items and services | $13.03 | General |
| Category: ENDOCRINOLOGY | ||||||
| 02/04/2019 | Novo Nordisk Inc | Saxenda (Drug) | Food and Beverage | In-kind items and services | $11.86 | General |
| Category: Obesity | ||||||
| 01/21/2019 | Amgen Inc. | Aimovig (Biological), Repatha | Food and Beverage | In-kind items and services | $25.33 | General |
| Category: Neuroscience | ||||||
| 01/15/2019 | Allergan Inc. | LINZESS (Drug) | Food and Beverage | In-kind items and services | $18.76 | General |
| Category: GASTROENTEROLOGY | ||||||
| 01/08/2019 | PFIZER INC. | LYRICA (Drug), EUCRISA, COLOGUARD | Food and Beverage | In-kind items and services | $15.76 | General |
| Category: NEUROSCIENCE;PAIN | ||||||
| 12/11/2018 | Nalpropion Pharmaceuticals, Inc. | CONTRAVE (Drug) | Food and Beverage | In-kind items and services | $12.61 | General |
| Category: Obesity | ||||||
| 12/10/2018 | Takeda Pharmaceuticals U.S.A., Inc. | Trintellix (Drug) | Food and Beverage | In-kind items and services | $22.59 | General |
| Category: Central Nervous System (CNS) | ||||||
| 12/04/2018 | Merck Sharp & Dohme Corporation | JANUVIA (Drug), BELSOMRA, STEGLATRO | Food and Beverage | In-kind items and services | $10.82 | General |
| Category: ENDOCRINOLOGY | ||||||
| 12/03/2018 | Boehringer Ingelheim Pharmaceuticals, Inc. | SPIRIVA RESPIMAT (Drug) | Food and Beverage | In-kind items and services | $13.07 | General |
| Category: RESPIRATORY | ||||||
| 11/27/2018 | Shire North American Group Inc | VYVANSE (Drug) | Food and Beverage | In-kind items and services | $14.89 | General |
| Category: NEUROSCIENCE | ||||||
| 11/26/2018 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $15.19 | General |
| 11/05/2018 | Amgen Inc. | Aimovig (Biological) | Food and Beverage | In-kind items and services | $14.31 | General |
| Category: Neuroscience | ||||||
| 10/23/2018 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $10.96 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 09/18/2018 | Takeda Pharmaceuticals U.S.A., Inc. | Trintellix (Drug) | Food and Beverage | In-kind items and services | $4.02 | General |
| Category: Central Nervous System (CNS) | ||||||
| 09/11/2018 | Upsher-Smith Laboratories LLC | QUDEXY XR Topiramate Extended Release Capsules (Drug) | Food and Beverage | In-kind items and services | $14.59 | General |
| Category: Neurology | ||||||
| 09/10/2018 | Amgen Inc. | Aimovig (Biological), Repatha | Food and Beverage | In-kind items and services | $18.65 | General |
| Category: Neuroscience | ||||||
| 09/04/2018 | Merck Sharp & Dohme Corporation | JANUVIA (Drug), STEGLATRO | Food and Beverage | In-kind items and services | $13.70 | General |
| Category: ENDOCRINOLOGY | ||||||
| 08/20/2018 | Shire North American Group Inc | VYVANSE (Drug) | Food and Beverage | In-kind items and services | $14.24 | General |
| Category: NEUROSCIENCE | ||||||
| 08/15/2018 | PFIZER INC. | CHANTIX (Drug), ELIQUIS | Food and Beverage | In-kind items and services | $11.37 | General |
| Category: NEUROSCIENCE;TOBACCO DEPENDENCE | ||||||
| 08/13/2018 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $10.77 | General |
| Category: Diabetes | ||||||
| 07/31/2018 | ARBOR PHARMACEUTICALS, INC. | Edarbi (Drug) | Food and Beverage | In-kind items and services | $12.07 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 07/16/2018 | Boehringer Ingelheim Pharmaceuticals, Inc. | STIOLTO (Drug) | Food and Beverage | In-kind items and services | $10.77 | General |
| Category: RESPIRATORY | ||||||
| 07/09/2018 | PFIZER INC. | LYRICA (Drug), EUCRISA | Food and Beverage | In-kind items and services | $16.27 | General |
| Category: NEUROSCIENCE;PAIN | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 239 | 343 | $45,977 | $20,855 |
| 2022 | 7 | 225 | 345 | $34,189 | $18,059 |
| 2021 | 11 | 238 | 366 | $33,210 | $17,807 |
| 2020 | 6 | 213 | 294 | $28,954 | $15,148 |
All Medicare Procedures & Services
30 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 47 | 75 | $17,867 | $6,529 | 36.5% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 49 | 49 | $7,840 | $6,055 | 77.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 45 | 93 | $15,665 | $5,439 | 34.7% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 22 | 22 | $2,640 | $1,582 | 59.9% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 54 | 82 | $1,394 | $688.80 | 49.4% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 22 | 22 | $572.00 | $560.56 | 98.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 49 | 121 | $14,481 | $7,227 | 49.9% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 40 | 40 | $6,400 | $5,052 | 78.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 37 | 45 | $8,742 | $3,653 | 41.8% |
| 90682 | Influenza vaccine, quadrivalent derived from recombinant dna | Office | 2022 | 14 | 15 | $1,695 | $1,022 | 60.3% |
| 99211 | Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | Office | 2022 | 16 | 19 | $873.62 | $425.69 | 48.7% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 14 | 15 | $467.20 | $412.36 | 88.3% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 55 | 90 | $1,530 | $266.85 | 17.4% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 44 | 104 | $10,920 | $5,950 | 54.5% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 32 | 48 | $8,160 | $4,229 | 51.8% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 31 | 31 | $4,960 | $3,998 | 80.6% |
| 87426 | Elisa detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antigen | Office | 2021 | 17 | 26 | $2,198 | $1,176 | 53.5% |
| 90682 | Vaccine for influenza derived from dna for injection into muscle, quadrivalent, preservative and antibiotic free | Office | 2021 | 12 | 12 | $810.00 | $783.12 | 96.7% |
| 87804 | Detection test by immunoassay for influenza virus | Office | 2021 | 14 | 32 | $1,920 | $529.60 | 27.6% |
| 99211 | Established patient outpatient visit, minimal presenting problem | Office | 2021 | 16 | 23 | $1,058 | $451.86 | 42.7% |
| 96372 | Injection beneath the skin or into muscle for therapy, diagnosis, or prevention | Office | 2021 | 14 | 23 | $1,495 | $231.84 | 15.5% |
| G0008 | Administration of influenza virus vaccine | Office | 2021 | 13 | 13 | $408.72 | $214.11 | 52.4% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2021 | 34 | 43 | $731.00 | $129.00 | 17.6% |
| 93000 | Routine ekg using at least 12 leads including interpretation and report | Office | 2021 | 11 | 11 | $550.00 | $114.70 | 20.9% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2020 | 45 | 45 | $7,200 | $5,171 | 71.8% |
About Dr. Matthew Moreland, DO
Dr. Matthew Moreland, DO is a Family Medicine healthcare provider based in Midlothian, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/06/2006. The National Provider Identifier (NPI) number assigned to this provider is 1083681381.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Matthew Moreland, DO has received a total of $1,656 in payments from pharmaceutical and medical device companies, with $29.45 received in 2024. These payments were reported across 105 transactions from 31 companies. The most common payment nature is "Food and Beverage" ($1,644).
As a Medicare-enrolled provider, Moreland has provided services to 915 Medicare beneficiaries, totaling 1,348 services with total Medicare billing of $71,869. Data is available for 4 years (2020–2023), covering 30 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Location Midlothian, TX
- Active Since 03/06/2006
- Last Updated 01/06/2010
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1083681381
Products in Payments
- Ozempic (Drug) $134.39
- Trintellix (Drug) $82.11
- FARXIGA (Drug) $81.51
- XARELTO (Drug) $77.53
- CHANTIX (Drug) $69.75
- VYVANSE (Drug) $62.76
- Aimovig (Biological) $58.29
- EVENITY (Biological) $42.30
- JANUVIA (Drug) $37.55
- TROKENDI XR (Drug) $36.50
- QUDEXY XR Topiramate Extended Release Capsules (Drug) $34.87
- UBRELVY (Drug) $34.67
- PREVNAR 13 (Biological) $32.21
- LYRICA (Drug) $32.03
- MOUNJARO (Drug) $31.18
- JARDIANCE (Drug) $30.26
- ADHANSIA XR (Drug) $29.47
- Victoza (Drug) $27.48
- INVOKANA (Drug) $27.21
- TOUJEO (Drug) $26.44
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Midlothian
Donald Sanders, M.d, M.D
Family Medicine — Payments: $18,297
Joseph Goddard, M.d, M.D
Family Medicine — Payments: $17,178
Dr. Joseph Castro, D.o, D.O
Family Medicine — Payments: $14,548
William Morrissette, M.d, M.D
Family Medicine — Payments: $13,896
Dr. Laura Aisenberg, M.d, M.D
Family Medicine — Payments: $13,402
Damian Covington, M. D, M. D
Family Medicine — Payments: $12,759